Quick Answer
iBio, Inc. reported Total Assets of $23.19 million for the year ending 2025.
- iBio, Inc. showed a decrease of -19.3% in Total Assets from 2024 to 2025.
- This data is from iBio, Inc.'s annual report (Form 10-K), filed with the SEC on September 5, 2025.
- XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $7.34 million | Q3 2011: $5.58 million | Q4 2011: $5.02 million | Q1 2012: $10.66 million | Q3 2012: $7.99 million | Q4 2012: $6.81 million | Q1 2013: $4.98 million | Q3 2013: $7.34 million | Q4 2013: $9.62 million | Q1 2014: $8.21 million | Q3 2014: $6.66 million | Q1 2015: $11.45 million | Q3 2015: $11.37 million | Q4 2015: $9.42 million | Q1 2016: $50.67 million | Q3 2016: $48.09 million | Q4 2016: $44.19 million | Q1 2017: $40.70 million | Q3 2017: $33.43 million | Q4 2017: $34.84 million | Q1 2018: $31.03 million | Q3 2018: $42.90 million | Q4 2018: $40.30 million | Q1 2019: $35.67 million | Q3 2019: $35.16 million | Q4 2019: $36.38 million | Q1 2020: $42.22 million | Q3 2020: $117.26 million | Q4 2020: $145.41 million | Q1 2021: $142.70 million | Q3 2021: $143.74 million | Q4 2021: $126.45 million | Q1 2022: $115.37 million | Q3 2022: $84.56 million | Q4 2022: $51.80 million | Q1 2023: $44.39 million | Q3 2023: $37.68 million | Q4 2023: $34.02 million | Q1 2024: $50.15 million | Q3 2024: $24.52 million | Q4 2024: $21.70 million | Q1 2025: $19.10 million | Q2 2025: $23.19 million | Q3 2025: $64.16 million | Q4 2025: $64.39 million.
- Over the full 15 years of available data (2012 to 2025), iBio, Inc.'s Total Assets has grown by 137.4%.
- Historical annual values: Fiscal year 2025: $23.19 million | Fiscal year 2024: $28.73 million | Fiscal year 2023: $41.21 million | Fiscal year 2022: $99.41 million | Fiscal year 2021: $146.97 million | Fiscal year 2020: $94.19 million | Fiscal year 2020: $42.22 million | Fiscal year 2019: $30.59 million | Fiscal year 2018: $43.08 million | Fiscal year 2017: $36.01 million | Fiscal year 2016: $51.60 million | Fiscal year 2015: $12.49 million | Fiscal year 2014: $6.49 million | Fiscal year 2013: $9.35 million | Fiscal year 2012: $9.77 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: